文献速递鼻科

鼻窦手术后疼痛管理:美国鼻科学会调查

Postoperative pain management after sinus surgery: a survey of the American Rhinologic Society.
PubMed 文献 · Int Forum Allergy Rhinol · 2018-07-18

该研究通过15项网络问卷对美国鼻科学会1770名成员进行调查,168人(9.49%)完成,旨在了解功能性内镜鼻窦手术(FESS)后的疼痛管理处方模式。结果显示94.05%的成员术后至少处方一种阿片类药物,平均27.38片,学术与私人执业医生在辅助疼痛管理策略上存在显著异质性。

要点

  • 94.05%的受访者FESS后处方阿片类药物,平均27.38片。
  • 学术医生较少处方布洛芬(p=0.0407)和非甾体抗炎药(NSAIDs)(p=0.032)。
  • 私人执业医生较少转诊疼痛管理(p=0.0117),更多转诊非传统疼痛管理(p=0.0164)。

核心结论

  • 大多数受访者在FESS后处方阿片类药物,处方数量与地理区域或执业环境无显著差异。
  • 学术与私人执业医生在辅助疼痛管理策略上存在显著异质性。
  • 在适当药物处置和循证术后疼痛管理方面存在认知差距。

研究设计与样本

  • 研究设计为基于网络的横断面调查,共15个条目。
  • 调查对象为美国鼻科学会1770名成员,最终168人完成问卷(9.49%),覆盖美国所有地区。
  • 采用线性回归分析评估提供者特征与处方模式之间的关联。

主要发现

  • 最常处方的药物为阿片类/非阿片类复方片剂。
  • 学术医生较少处方布洛芬(p=0.0407),较少处方NSAIDs总体(p=0.032)。
  • 私人执业医生较少转诊疼痛管理(p=0.0117),更多转诊非传统疼痛管理(p=0.0164);学术医生更可能转诊疼痛管理(p=0.00121)。
  • 对疼痛控制的感知与NSAIDs处方或阿片类药物片数之间无关联。

关键数值与推荐

  • 平均阿片类药物处方片数:27.38片。
  • 学术医生处方布洛芬的差异:p=0.0407;处方NSAIDs的差异:p=0.032。
  • 私人执业医生转诊疼痛管理的差异:p=0.0117;转诊非传统疼痛管理的差异:p=0.0164。
  • 学术医生转诊疼痛管理的差异:p=0.00121。

临床怎么用

  • 调查结果提示FESS术后阿片类药物处方普遍,但辅助疼痛管理策略因执业环境而异。
  • 学术与私人执业医生在NSAIDs使用和疼痛管理转诊模式上存在差异,可供临床参考。
  • 需关注药物处置教育和循证术后疼痛管理知识的普及。

局限性

  • 问卷回复率较低(9.49%),可能存在无应答偏倚。
  • 调查基于自我报告,可能受回忆偏倚或社会期望偏倚影响。
  • 研究为横断面设计,无法推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative pain management is controversial as there are no current guidelines to direct clinical practice. The purpose of this study was to demonstrate prescribing patterns for pain management after functional endoscopic sinus surgery (FESS). METHODS: A 15-item web-based survey was electronically distributed to 1770 members of the American Rhinologic Society (ARS). Linear regression analysis was used to determine associations between providers and prescribing patterns. RESULTS: The survey was completed by 168 members (9.49%), representing all regions of the United States. The most commonly prescribed medications were opioid/non-opioid combination pills. One hundred fifty-seven of 168 members (94.05%) prescribed at least one kind of opioid after FESS, with an average of 27.38 pills. The majority of surveyed members worked in private or academic settings. Academic physicians were less likely to prescribe ibuprofen (p = 0.0407), and nonsteroidal anti-inflammatory drugs (NSAIDs) in general (p = 0.032). Physicians in private practice were less likely to refer patients to pain management (p = 0.0117), but more likely to refer patients to nontraditional forms of pain management (p = 0.0164). Academic physicians were more likely to refer patients to pain management (p = 0.00121). There was no association between perception of pain control and the prescription of NSAIDs or with number of opioid pills prescribed. CONCLUSION: Most providers prescribed opioids after FESS. There was no significant difference in the number of opioids prescribed based on geography or practice setting. There was significant heterogeneity in the adjuvant pain management strategy between academic and private practitioners. Most members provided patient education and few reported poor pain control. However, there was a gap in understanding of appropriate medication disposal and evidence-based postoperative pain management.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Gray ML, Fan CJ, Kappauf C, et al. Postoperative pain management after sinus surgery: a survey of the American Rhinologic Society. Int Forum Allergy Rhinol. 2018. PMID: 30019397. doi:10.1002/alr.22181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。